Vanguard Group Inc. Sells 47,764 Shares of Simulations Plus, Inc. $SLP

Key Points

• Vanguard Group Inc. reduced its stake in Simulations Plus by 4.2%, selling 47,764 shares, and now holds approximately 5.46% of the company’s stock valued at $26.93 million.
• Other institutional investors such as Barclays PLC and First Trust Advisors LP have increased their stakes in Simulations Plus during the fourth quarter.
• Simulations Plus reported $0.45 EPS for its latest quarter, exceeding analysts' estimates, but its revenue of $20.36 million fell short of expectations.

Vanguard Group Inc. lowered its position in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 4.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,098,365 shares of the technology company's stock after selling 47,764 shares during the period. Vanguard Group Inc. owned about 5.46% of Simulations Plus worth $26,932,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Fifth Third Bancorp increased its position in shares of Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock valued at $36,000 after buying an additional 375 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Simulations Plus by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company's stock valued at $254,000 after buying an additional 380 shares in the last quarter. Barclays PLC increased its position in shares of Simulations Plus by 2.7% in the 4th quarter. Barclays PLC now owns 29,229 shares of the technology company's stock valued at $815,000 after buying an additional 756 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after buying an additional 764 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Simulations Plus by 15.6% in the 1st quarter. US Bancorp DE now owns 6,576 shares of the technology company's stock valued at $161,000 after buying an additional 889 shares in the last quarter. Institutional investors own 78.08% of the company's stock.

Simulations Plus Stock Down 0.1%

Shares of SLP stock traded down $0.01 during trading on Wednesday, reaching $14.38. The company's stock had a trading volume of 246,495 shares, compared to its average volume of 363,392. The business has a fifty day moving average price of $14.67 and a 200-day moving average price of $23.63. The company has a market cap of $289.47 million, a price-to-earnings ratio of -4.57 and a beta of 0.85. Simulations Plus, Inc. has a one year low of $12.39 and a one year high of $37.67.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.26 by $0.19. The business had revenue of $20.36 million for the quarter, compared to analyst estimates of $22.83 million. Simulations Plus had a negative net margin of 78.63% and a positive return on equity of 11.62%. The firm's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.27 earnings per share. Research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on SLP shares. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a research note on Tuesday, July 15th. Stephens cut their price target on shares of Simulations Plus from $28.00 to $20.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 15th. Craig Hallum cut their price target on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a research note on Friday, June 13th. Zacks Research raised shares of Simulations Plus to a "hold" rating in a research note on Tuesday, August 12th. Finally, KeyCorp lowered shares of Simulations Plus from an "overweight" rating to a "sector weight" rating in a research note on Tuesday, July 15th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Simulations Plus presently has a consensus rating of "Moderate Buy" and an average target price of $26.50.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.